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OBJECTIVE: The growth plate consists of organized hyaline cartilage and serves as a scaffold for endochondral
ossification, a process that mediates longitudinal bone growth. Based on evidence showing that the oral
administration of glucosamine sulfate (GS) and/or chondroitin sulfate (CS) is clinically valuable for the
treatment of compromised articular cartilage, the current study evaluated the effects of these molecules on the
tibial epiphyseal growth plate in female rats.
METHOD: The animals were divided into two control groups, including vehicle treatment for 45 days (GC45)
and 60 days (GC60) and six ovariectomized (OVX) groups, including vehicle treatment for 45 days (GV45), GS for
45 days (GE45GS), GS+CS for 45 days (GE45GS+CS), vehicle for 60 days (GV60), GS for 60 days (GE60GS) and
GS+CS for 60 days (GE60GS+CS). At the end of treatment, the tibias were dissected, decalcified and processed
for paraffin embedding. Morphological and morphometric methods were employed for analyzing the distal
tibial growth plates using picrosirius red staining and the samples were processed for histochemical hyaluronan
detection. Morphometric analyses were performed using the 6.0ProPlusH Image system.
RESULTS: Notably, after 60 days of treatment, the number of proliferative chondrocytes increased two-fold, the
percentage of remaining cartilage increased four-fold and the percentage of trabecular bone increased three-
fold in comparison to the control animals.
CONCLUSION: GS and CS treatment drugs led to marked cellular proliferation of the growth plate and bone
formation, showing that drug targeting of the tibial epiphyseal growth plate promoted longitudinal bone
growth.
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& INTRODUCTION
Bone formation through endochondral ossification is a
process initiated by mesenchymal cell condensation that
forms a cartilaginous scaffold that is later replaced by bone
(1). However, in diarthroid joints, not all cartilage of the
scaffold is substituted by bone and the growth plate remains
responsible for further endochondral ossification (2-3).
The outcome of this process is chondrocyte differentia-
tion, which leads to subsequent proliferation and hyper-
trophy and the concomitant expression of specific genes
in cartilaginous tissue (4). Terminal differentiation of the
cartilage induces the mineralization of cartilaginous extra-
cellular matrix (ECM) and death of chondrocytes by
means of programmed cellular death (PCD) (5). During
the longitudinal growth period, the rate of cartilage
formation is balanced by substitution with bone tissue,
which makes the growth plate size remain constant. For this
reason, hypertrophic chondrocytes must be eliminated (4-7).
At the end of ossification, the growth plate decreases in
thickness, although the articular cartilage remains (8-9).
However, both types of tissue undergo age-related changes,
which increase the risk of articular cartilage degeneration
because of decreased bone formation and may reduce or
hinder movement through the joint. Thus, the discovery of
new agents able to protect this tissue is needed (10).
The growth plate articular cartilage is known for its low
capacity to self repair, which is likely associated with
the lack of blood supply, reduced mobility and a limited
number of progenitor cells (1). Therefore, some authors
have suggested that supplementation with glucosamine
sulfate (GS), alone or in combination with chondroitin
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sulfate (CS+GS), can stimulate regeneration of this cartilage
through chondrogenesis of mesenchymal cells and reduce
the risk of cartilage damage via proteoglycan synthesis.
Additionally, these compounds may alleviate pain in
cases of osteoarthritis and may possess anti-inflammatory
activity that can alter the progression of the disease (11).
In addition, cartilage degeneration is a serious problem
for post-menopausal and elderly women and some
studies suggest that estrogen deficiency plays a role in its
development (12).
Surgical bilateral ovariectomy is used to induce hypogo-
nadism in rats, which results in the degeneration of cartilage
and bone (13) and studies using this experimental animal
model are important for evaluating the effects of various
substances on cartilage damage. However, the effects of GS
alone or in combination with CS on the growth plate are not
well known, although their chondroprotective effects for the
treatment of osteoarthritis have been advocated by some
authors (14-16). To test the hypothesis that GS and CS can
influence the growth plate, ovariectomized (OVX) adults
female rats were studied.
& METHODS
All experimental protocols were approved by the
Research Ethics Committee on Animal Experimentation of
Sa˜o Paulo Federal University (UNIFESP-EPM/project 1179/
05) and the animals were maintained in accordance with the
National Institutes of Health guidelines for the Care and
Use of Laboratory Animals (17).
Animals
A total of 80, four-month-old virgin rats (Rattus norvegicus
albinus) weighing 250–300 g were used. The animals were
provided by the Center for the Development of Experimental
Models (CEDEME) of the Federal University of Sa˜o Paulo
(UNIFESP - EPM) and were kept in plastic cages with
controlled light and temperature, and fed a soy-free diet and
water ad libitum.
The rats were submitted to colpocitological examination
for 21 consecutive days for the evaluation of normal estrous
cycles, after which time 60 animals were subjected to
bilateral OVX. A post-surgical period of 28 days was
observed in order to obtain significant depletion of the
estrogen levels (18). The rats were randomly divided into
the following six experimental groups, each consisting of
ten animals: GV45 – treatment with vehicle (NaCl 0.9%) for
45 days; GE45GS – treatment with GS (9 mg/kg) for 45
days; GE45GS+CS – treatment with GS (9 mg/kg) + CS
(9 mg/kg) for 45 days; GV60 – treatment with NaCl 0.9% for
60 days; GE60GS – treatment with GS (9 mg/kg) for 60 days
and GE60GS+CS – treatment with GS (9 mg/kg) + CS
(9 mg/kg) for 60 days. The remaining intact animals in the
proestrous phase (n = 20) were used as controls, which
comprised the two following groups of ten animals each:
GC45 – treatment with NaCl 0.9% for 45 days and GC60 –
treatment with NaCl 0.9% for 60 days. Treatments were
given by gavage (0.5 mL per day), always at 04:00 p.m. and
the drug dosing protocols were selected based on previous
experimental data.
At the end of the treatment, all animals were euthanized
with an excess of anesthesia (xylazine 20 mg/kg plus
ketamine 100 mg/kg, administered intraperitoneally (i.p.)).
The tibias were dissected and fixed in 10% phosphate-buffered
formaldehyde for 24 h and then decalcified in 10% buffered
formic acid for 7 days (19). The fragments were then
dehydrated and processed for paraffin embedding. Eight 4-
mm-thick sections were prepared for each sample, with two
used for hematoxylin-eosin (H.E.) staining and two used for
sirius red-hematoxylin staining. The remaining four slices
were processed for immunohistochemical analyses. The
slices were used for histological and morphometrical
evaluations.
Immunoexpression of hyaluronan
The sections were rehydrated in a graded series of ethanol
and water. They were then incubated for 30 min in 3%
hydrogen peroxidase in PBS (Amersham Life Sciences
Buckinghamshire, England, UK), followed by b-HABP
(15150; Seikagaku Corporation, Chiyoda-ku, Japan) in 1%
BSA/PBS for 1 h at 40 C˚. Then, the sections were pre-
digested with 50 ng of Streptomyces hyaluronidase in PBS
(Sigma-Aldrich Co., St Louis, Missouri, USA), which
specifically degrades hyaluronan acid (HA), for 1 h at
37 C˚. This step was followed by incubation in horseradish
peroxidase-labeled streptavidin solution (NOVOCastra
Super Novostain Reacting ABC Kit, Leica Microsystem
Inc, Buffalo Grove, USA) for 1 h at room temperature, 0.05%
3.39-diaminobenzidine (NOVOCastra Liquid DAB Substrate
Kit NCL-L-DAB, Leica Microsystem Inc., Buffalo Grove,
USA) and 0.03% hydrogen peroxide in PBS and counter-
staining with methyl green (Sigma-Aldrich Co Diagnostics,
St. Louis, Missouri, USA) for 30 min. The prepared speci-
mens were examined by light microscopy (Nikon E800
Eclipse, Nikon Imaging Japan Inc, Japan) and digital images
of growth plate area were obtained. Quantification was
obtained by evaluating the brownish color density resulting
from the binding of endogenous HA to the biotinylated
probe (20-21).
Histomorphometric analysis
The central two-thirds of the growth plate sections
(saggital area) of the distal epiphyseal growth plate and
the subjacent newly formed bone were used in the
histomorphometric analysis. Images were captured with a
digital system (light microscope connected to Nikon
DXM1200FH digital camera) using Nikon software (ACT-1
2.62 version 2000H). The histomorphometric measures were
analyzed using Image Pro Plus 6.0 software (Media
Cybernetics). Ten microscope fields per histological section
(total of five slices per animal) were analyzed using a 36-
point intersection grid (Weibel’s reticulum to measure the
newly formed bone (remaining cartilage, trabecular bone
and the bone marrow) and the growth plate cartilage
activity (thickness of the resting zone (RZ), proliferative
zone (PZ) and hypertrophic zone (HZ), along with total
zone estimates)). To prevent overcounting due to the
reticular extremity effect, which has been reported, two
lines of the grid extremities were not considered. In
addition, five different slices from each animal were
analyzed with the Image Pro Plus 6.0 digital system to
determine the chondrocyte number and the thickness of the
RZ, HZ and PZ of the growth plate. Ten areas of five
different slices from each animal were analyzed under 4006
magnification and the intensity of hyaluronan staining and
the quantitation by optical density (O.D.) of positively
marked cells were determined (22).
Osteoblast proliferation in rats
Wolff RB
CLINICS 2014;69(12):847-853
848
Statistical analysis
The data from histomorphometric analyses are given as
the mean¡SD. The statistics software GraphPad Prism
version 4.02 for Windows (San Diego, California) was used
to calculate the means and mean deviations and differences
were evaluated by analysis of variance (ANOVA), para-
metric tests (testing differences between two or more
variables), Bonferroni test and nonparametric tests (testing
independent samples). Statistical significance was set at
p,0.05 (23).
& RESULTS
Morphology
The cellular arrangement of the epiphyseal disk in the
GV45 and GV60 groups was disorganized and the remain-
ing cartilage and trabecular bone area were decreased.
Significant reductions in the number of resting and
proliferative chondrocytes and PZ thickness were also
noticed. Moreover, these groups showed increases in RZ
and HZ thickness as well as the bone marrow area (Figure 1).
Compared to GV45 and GV60, the GE45GS, GE45GS+CS,
GE60GS and GE60GS+CS groups presented an organized
cellular arrangement and increases in the number of resting
and proliferative chondrocytes, PZ thickness, remaining
cartilage and the trabecular bone area. In addition, these
groups showed a decrease in the number of hypertrophic
chondrocytes in the bone marrow area, as well as a decrease
in RZ and HZ thickness. In all cases, the most significant
alterations of these histomorphological parameters occurred
60 days after treatment. Figure 2 shows that in all groups,
evident hyaluronan staining was only present in the HZ.
Histomorphometric assessment
The histomorphometric data regarding the effect of GS
and GS+CS treatments for 45 or 60 days on the growth plate
are shown in Table 1. The percentages of resting and
proliferative chondrocytes in the GE45GS, GE45GS+CS,
GE60GS and GE60GS+CS groups were higher than those
observed in the GV45 and GV60 groups (p,0.001). The
percentages of hypertrophic chondrocytes in groups
GE45GS, GE60GS and GE60GS+CS were significantly lower
than those in groups GV45 and GV60 (p,0.01). The resting
and hypertrophic cartilage thickness in groups GE45GS,
GE45GS+CS, GE60GS and GE60GS+CS was lower than that
observed in groups GV45 and GV60 (p,0.01). Moreover, the
thickness of the proliferative cartilage in groups GE45GS,
GE45GS+CS, GE60GS and GE60GS+CS was significantly
increased when compared to that in groups GV45 and GV60
(p,0.001). No difference was found among the groups with
respect to the total cartilage thickness of the growth plate.
Regarding the bone formation area, the percentages of
remaining cartilage and trabecular bone in groups GE45GS,
GE45GS+CS, GE60GS and GE60GS+CS were all consistently
higher than those found in groups GV45 and GV60
(p,0.001). The percentages of bone marrow area in groups
GE45GS, GE45GS+CS, GE60GS and GE60GS+CS were
significantly lower than those in groups GV45 and GV60
(p,0.001). Hyaluronan content in the growth plate, obtained
through optical density (O.D.) measurements, revealed that
only the GE60GS and GE60GS+CS groups showed signifi-
cant differences, with an increased O.D. value for hyper-
trophic chondrocytes.
& DISCUSSION
GS and CS are found naturally in connective tissues and
as constituents of glycosaminoglycans, the building blocks
of the large aggregating proteoglycans of the cartilage that
are important for cartilage health. CS is a major component
of glycosaminoglycan, while GS is a constituent of the
disaccharide building blocks of CS. These structures play a
role in the cartilage matrix and may improve the strength of
this tissue (11,23). Our data suggest that GS may act to
improve the cartilage in OVX rats, particularly after 60 days
of treatment.
It is important to emphasize that our histological analysis
of the epiphyseal growth plate in the control groups showed
similar findings as those described by Roach et al. (9) for
adult rats, with three distinct hyaline cartilage zones (5,9).
Therefore, the control animals in our study were similar to
those previously described in the literature.
The rate at which chondrocytes carry out these events is
called ‘‘turnover’’, and this process varies from species to
species (24-25). The ossification process occurs in function-
ally active growth plates and requires the correct spatial and
temporal regulation of a series of events. During the
differentiation of growth plate chondrocytes, a complex
interaction exists among systemic, paracrine, autocrine and
intrinsic factors, which can change with aging (senescence)
(26-27). In some mammals, including humans, the growth
plate gradually gets thinner, ossifies and ceases longitudinal
growth during adulthood. However, in some small rodents,
such as rats, the growth plate is maintained, showing
continued longitudinal growth throughout the lifespan of
the animal. In older rats, the growth plate structure and
thickness is maintained but is not functional and long-
itudinal growth ceases at a certain point (28-31). For this
reason, the rat model may be helpful in evaluating the
effects of GS on the cartilage.
Some studies have suggested that estrogen helps to
regulate chondrocyte maturation but does not directly
stimulate ossification. Instead, this sexual hormone speeds
up the normal process of senescence and the cessation of
longitudinal growth via the exhaustion of the proliferative
potential of chondrocytes (32-34). To accelerate the senes-
cence process in adult animals, OVX was performed in our
study. After this procedure, which was followed by a
decrease in estrogen, some histological structures similar to
those found in older animals were observed.
The difference of 15 treatment days between the groups
was significant, showing that the senescence process was
more accentuated in the 60-day OVX group treated with
vehicle. In fact, these animals presented morphological and
structural changes on the growth plate, with an increase in
hypertrophic chondrocytes and a decrease in proliferative
chondrocytes (3,5,9). This effect was similar to data reported
by Tivesten et al. (12). Additionally, an acellular region was
observed in the RZ, along with disorganization in the PZ
and HZ arrangement and loss of synchrony of the cartilage
zones of growth plate. All of these events increase with
senescence, as previously reported by Helmtrud et al. (10) in
their study of rat growth plates after the cessation of
longitudinal growth.
GS and CS have been used separately or in association in
the treatment of degenerative joint processes (11,14-15,24)
and they have been shown to participate in component
reconstitution of the ECM of the hyaline cartilage in some
CLINICS 2014;69(12):847-853 Osteoblast proliferation in rats
Wolff RB
849
joints (14,35). In our study about the effects of these drugs
on the growth plate, treatment with GS alone was similar to
treatment with GS in association with CS. As evidenced by
Morelli et al. (16), these drugs have a delayed action on the
cartilage of the joint and they need to be applied for at least
one month prior to the manifestation of improvements in
the degenerated cartilage.
The action of GS may be explained by the acceleration of
the longitudinal growth of the plate (14). In rats, this process
is independent of the influence of estrogen. This effect on
bone longitudinal growth is referred to as ‘‘catch-up
growth’’ and is intrinsic to the growth plate. Van der
Eerden et al. (36) suggested that this action may occur after
retardation in longitudinal growth of the plate, which is
Figure 1 - Growth plate photomicrographs of the following: A – non-OVX rats treated for 45 days with vehicle (GC45); B – OVX rats
treated for 45 days with vehicle (GV45); C – non-OVX rats treated for 60 days with vehicle (GC60); D – OVX rats treated for 60 days with
vehicle (GV60), E – OVX rats treated for 45 days with GS (GE45GS); F – OVX rats treated for 45 days with GS+CS (GE45GS+CS); G – OVX
rats treated for 60 days with GS (GE60GS); and H – OVX rats treated for 60 days with GS+CS (GE60GS+CS). Sirius red-hematoxylin
staining. (r: resting cartilage; p: proliferative cartilage; h: hypertrophic cartilage, c: remaining cartilage, o: trabecular bone, m: bone
marrow). Scale bar = 75 mm.
Osteoblast proliferation in rats
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associated with the loss of mitotic activity of proliferative
chondrocytes. After this process, the proliferative capacity
of the chondrocytes returns, but is much accentuated to
compensate for the previous lack of longitudinal growth.
Therefore, if animals show increased ingestion of important
components of the matrix during this phase, the cartilage
damage may be lessened.
The quantitation of hyaluronan in hypertrophic chondro-
cytes in our study should be emphasized. Pavasant et al.
(20) and Suzuki et al. (22) showed that the expression of
hyaluronan in hypertrophic chondrocytes was evidenced in
the pericellular region, between the chondrocyte and its
territorial matrix. These chondrocytes synthesize a great
amount of hyaluronan, which, together with aggrecan, is
Figure 2 - Growth plate photomicrographs of the following: A: non-OVX rats treated for 45 days with vehicle (GC45); B: OVX rats
treated for 45 days with vehicle (GV45); C: non-OVX rats treated for 60 days with vehicle (GC60); D: OVX rats treated for 60 days with
vehicle (GV60), E: OVX rats treated for 45 days with GS (GE45GS); F: OVX rats treated for 45 days with GS+CS (GE45GS+CS); G: OVX rats
treated for 60 days with GS (GE60GS); and H: OVX rats treated for 60 days with GS+CS (GE60GS+CS). Histochemical staining of
hyaluronan counterstained with methyl green (arrows). Scale bar= 50 mm.
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able to absorb large amounts of water, thus increasing the
osmotic pressure and expanding the lacunae. The hyalur-
onan content found in this region is directly proportional to
the chondrocyte lacunae size, but its presence is not
necessary to keep the lacunae expanded. This expansion
during maturation of the growth plate is therefore essential
for its longitudinal growth. Nilsson & Baron (25) showed
that the histochemical hyaluronan localization is directly
correlated with the chondrocyte total area and that GS
treatment may stimulate hypertrophic chondrocytes to
synthesize additional hyaluronan.
When GS and CS were administered as combination
treatment for 60 days, female rats showed more effective
maintenance and improvement of the proliferation of the
epiphyseal growth plate as well as increased longitudinal
bone growth. While our results were obtained in rat models,
Provenza et al. (37), Sawitzke et al. (38) and Gregory et al.
(39) have shown that the treatment of post menopausal
women with GS and CS for more than 4 months can also be
effective for improving articular function and reducing
pain. Therefore, long-term administration of GS and CS in
postmenopausal women with osteoarthritis caused by
hypogonadism should be evaluated for its effects on bone
maintenance.
& ACKNOWLEDGMENTS
This study was supported by FAPESP (Fundac¸a˜o de Apoio a` Pesquisa do
Estado de Sa˜o Paulo - 05/57914-8, scholarship).
& REFERENCES
1. Schrier L, Ferns SP, Barnes KM, Emons JAM, Newman EI, Nilsson
O. Depletion of resting zone chondrocytes during growth plate
senescence. J Endocr. 2006;189(1):27-36, http://dx.doi.org/10.1677/joe.
1.06489.
2. Chrysis D, Nilsson O, Ritzen EM, Savendahl M. Apoptosis is
developmentally regulated in rat growth plate. Endocrine.
2002;18(3):271–8, http://dx.doi.org/10.1385/ENDO:18:3:271.
3. Wuelling M, Vortkamp A. Chondrocyte proliferation and differation.
Endocr Dev. 2011;21(3):1-11, http://dx.doi.org/10.1159/000328081.
4. Mackie EJ, Tatarczuch L, Mirams M. 2. The skeleton: a multi-functional
complex organ. The growth plate chondrocyte and endochondral
ossification. J Endocrinol. 2011;211(2):109-21, http://dx.doi.org/10.
1530/JOE-11-0048.
5. Mackie EJ, Ahmed YA, Tartarczuch L, Chen KS, Mirams M. Endocondral
ossification: how is converted into bone in the developing skeleton.
Int J Biochem Cell Biol. 2008;40(1):46-62.
6. Farnum CE, Wilsman NJ. Morphologic stages of the terminal hyper-
throphic chondrocyte of growth plate cartilage. Anat Rec.
1987;219(3):221–32, http://dx.doi.org/10.1002/ar.1092190303.
7. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep.
2003;5(3):222–6, http://dx.doi.org/10.1007/s11926-003-0071-z.
8. Garimella R, Bi X, Camacho N, Sipe J, Anderson HC. Primary culture of
rat growth plate chondrocytes: an in vitro model growth plate histotype,
matrix vesicle biogenesis and mineralization. Bone. 2004;34(6):961-70,
http://dx.doi.org/10.1016/j.bone.2004.02.010.
9. Roach HI, Mentha G, Oreffo ROC, Clarke NMP, Cooper C. Temporal
analysis of rat growth plates: cessation of growth with age despite
presence of a physis. J Histochem Cytochem. 2003;51(3):373–83, http://
dx.doi.org/10.1177/002215540305100312.
10. Felson DT. Osteoarthritis: New Insights Part 2, NIH Conference:
Treatment Approaches. Ann Intern Med. 2000;133(9):726–36, http://dx.
doi.org/10.7326/0003-4819-133-9-200011070-00015.
11. Henrotin Y, Marty M, Mobasheri A. What is the current status of
chondroitin sulfate and glucosamine forthe treatment of knee osteoar-
thritis? Maturitas. 2014;78(3):184–87, http://dx.doi.org/10.1016/j.
maturitas.2014.04.015.
12. Tivesten A, Moverare-Skrtic S, Chagin A, Veken K, Salmon P, et al.
Additive protective effects of estrogen and androgen treatment on
trabecular bone in ovariectomized rats. J Bone Min Res. 2004;19(11):1833–
44, http://dx.doi.org/10.1359/JBMR.040819.
13. Pernille HA, Tanko LB, Andersen TL, Lundberg CV, Mo JA, et al.
Ovarietomized rats as a model of postmenopausal osteoarthritis:
validation and application. Arthritis Res Ther. 2004;6(2):169-80.
14. Hua J, Suguro S, Hirano S, Sakamoto K, Nagaoka I. Preventive actions of
a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res.
2005;54(3):127-32, http://dx.doi.org/10.1007/s00011-004-1333-6.
15. Hungerford DS, Jones LC. Glucosamine and Chondroitin Sulfate are
effective in the management of osteoarthritis. J Arthroplasty.
2003;18(1):5–9, http://dx.doi.org/10.1054/arth.2003.50067.
Table 1 - Morphometrical data of tibial histological analyses after the treatment of OVX rats with GS (9 mg/kg) and/or
CS (9 mg/kg) for 45 or 60 days, as indicated (for further details, see materials and methods section). Each group
consisted of 10 rats and the values correspond to the mean ¡ SD.
NUMBER OF CHONDROCYTES (%)
CARTILAGE ZONES GE45GS GE60GS GE45GS+CS GE60GS+CS GV45 GV60 GC45 GC60
Resting 16.0¡0.4a 19.5¡0.5a 15.0¡3.0a 17.5¡3.4a 10.0¡0.8 8.0¡1.2 14.0¡2.3 15.0¡0.4
Proliferative 55.0¡3.7a 58.5¡0.6a 51.5¡5.4b 57.0¡8.7a 47.5¡3.9 43.0¡3.0 49.5¡1.4 47.5¡3.7
Hypertrophic 29.0¡3.0b 22.0¡0.8a 33.5¡2.1 25.5¡1.1a 42.5¡4.1 49.0¡2.2 36.5¡2.1 37.5¡0.1
CARTILAGE THICKNESS (mm)
CARTILAGE ZONES GE45GS GE60GS GE45GS+CS GE60GS+CS GV45 GV60 GC45 GC60
Resting 36.0¡1.5 31.5¡5.5a 35.0¡0.6c 32.5¡1.0a 44.0¡1.4 47.5¡0.7 38.5¡0.7 39.5¡0.7
Proliferative 74.5¡0.6a 81.5¡1.5a 70.0¡1.5b 77.0¡3.5a 58.0¡0.0 48.0¡1.4 70.0¡0.0 66.5¡0.0
Hypertrophic 47.5¡2.3b 43.5¡0.6a 51.0¡3.1 47.0¡1.5a 56.0¡1.4 63.0¡1.4 48.5¡1.4 50.5¡0.7
Total 158.0¡0.0 156.5¡5.0 156.0¡2.1 156.5¡3.6 158.0¡2.1 158.5¡1.4 157.0¡3.5 156.5¡1.4
BONE FORMATION AREA (%)
AREA GE45GS GE60GS GE45GS+CS GE60GS+CS GV45 GV60 GC45 GC60
Remaining Cartilage 11.5¡0.5a 13.5¡0.5a 10.5¡0.1a 13.0¡0.1a 6.0¡0.5 3.5¡0.1 9.0¡1.7 6.5¡0.0
Trabecular Bone 13.5¡0.2a 15.0¡0.1a 10.5¡0.1 14.5¡0.3a 9.0¡1.4 5.0¡1.0 11.5¡0.4 11.5¡1.1
Bone Marrow 11.0¡0.4a 8.0¡0.6a 13.0¡0.5a 9.0¡0.6a 21.5¡1.4 27.5¡1.1 15.5¡2.0 18.0¡1.1
HYALURONAN QUANTIFICATION (O.D. units)
CARTILAGE ZONE GE45GS GE60GS GE45GS+CS GE60GS+CS GV45 GV60 GC45 GC60
Hypertrophic 36.4¡1.9 41.8¡1.1b 34.3¡0.4 41.3¡2.0b 33.0¡2.3 31.20¡1.9 41.0¡1.1 38.8¡0.8
Statistically significant values: a p,0.001; b p,0.01; c p,0.05; mm - micrometers; %: percentage; O.D.: optical density.
Osteoblast proliferation in rats
Wolff RB
CLINICS 2014;69(12):847-853
852
16. Morelli V, Naquin C, Weaver V. Alternative therapies for traditional
disease states: osteoarthritis. Ame Fam Phys. 2003;67(2):339-44.
17. Andersen ML, D9Almeida V, Ko GM Kawakami R, Martins PJF,
Magalha˜es LE, et al. Ethical principles and practical use of experimental
animals. Dept Psychobiology, Federal University of Sa˜o Paulo School of
Medicine. 2009.
18. Allen E. The estrous cycle in the mouse. Am J Anat. 1992;30(3):297-348.
19. Kiernan JA. Histological and histochemical methods. Theory and
practice. Arnold Editor. Third edition. 2001.
20. Pavasant P, Shirazi T, Underhill CB. Hyaluronan contributes to the
enlargement of hypertrophic lacunae in the growth plate. J Cell Sci.
1996;109(Pt2):327-34.
21. Suzuki A, Tanimoto K, Ohno S, Nakatani Y, Honda K, et al. The
metabolism of hyaluronan in cultured rabbit growth plate chondrocytes
during differentiation. Biochem Biophysic Acta. 2005;1743(1-2):57–63,
http://dx.doi.org/10.1016/j.bbamcr.2004.08.007.
22. Lacerda CAM. Stereological tools in biomedical research. An Acad Bras
Cienc. 2003;75(4):469–86.
23. Fowler J, Cohen L Practical statistics for field biology. Open University
Press, Buckingham, Inglaterra 1990.
24. Blitterswijk W, Van de Nes J, Wuisman P. Glucosamine and chondroitin
sulfate supplementation to treat symptomatic disc degeneration:
Biochemichal rationale and case report. BMC Complementary and
alternative Medicine. 2003;3(2):1-8.
25. Nilsson O, Baron J. Impact of growth plate senescence on catch-up
growth and epiphyseal fusion Review. Pediatr Nephrol. 2005;20(3):319–
22, http://dx.doi.org/10.1007/s00467-004-1689-4.
26. Lui JC, Nilsson O, Baron J. Growth Plate Senescence and Catch-Up
Growth. Endocr Dev. Basel. 2011;21:23–9, http://dx.doi.org/10.1159/
000328117.
27. Stevens DA, Williams GR. Hormonal regulation of chondrocyte
differentiation and endochondral bone formation. Mol Cell Endocrinol.
1999;151(1-2):195-204, http://dx.doi.org/10.1016/S0303-7207(99)00037-4.
28. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine
Regulation of the Growth Plate. Horm Res. 2005;64(4):157–65, http://
dx.doi.org/10.1159/000088791.
29. Provot S, Schipani E. Molecular mechanisms of endochondral bone
development. Bioch Bioph Res Com. 2008;328(3):658-65.
30. Irie T, Aizawa T, Kokubum S. The role of sex hormones in the kinetics of
chondrocytes in the growth plate. A study in the rabbit. J Bone Joint Sur.
2005;87(9):1278-84.
31. Wolff RB, Gomes RC, Verna C, Maioral GC, Rampazo TC, et al.
Molecular features of sexual steroids on cartilage and bone. Rev
Assoc med Bras. 2012;58(4):493-7, http://dx.doi.org/10.1590/S0104-
42302012000400023.
32. Frenkel B, Hong A, Banival SK, Coetzee GA, Ohlsson C, Khalid O.
Regulation of adult bone turnover by sex steroids. J Cel Physiol.
2010;224(2):305-310, http://dx.doi.org/10.1002/jcp.22159.
33. Karimian E, Sa¨vendahl L. Estrogen signaling in growth plate cartilage.
Endocr Dev. 2011;21:42-51, http://dx.doi.org/10.1159/000328126.
34. Van der Eerden BCJ, Karperien M, Wit JM. Systemic and local regulation
of the growth plate. Endocr Rev. 2003;24(6):782-801, http://dx.doi.org/
10.1210/er.2002-0033.
35. Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, et al.
Glucosamine sulfate reduces osteoarthritis progression in postmenopau-
sal women with knee osteoarthritis: evidence from two 3-year studies.
Menopause. 2004;11(2):134-5.
36. Van der Eerden BCJ, Van de Ven J, Lowik CWGM, Wit JM, Karperien M.
Sex steroid metabolism in the tibial growth plate of the rat.
Endocrinology. 2002;143(10):4048-55, http://dx.doi.org/10.1210/en.
2002-220093.
37. Provenza JR, Shinjo SK, Silva JM, Peron CR, Rocha FA. Combined
glucosamine and chondroitin sulfate, once or three times daily, provides
clinically relevant analgesia in knee osteoarthritis. Clin Rheumatol. 2014
Aug 3. [Epub ahead of print].
38. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Harris CL, et al. Clinical
efficacy and safety of glucosamine, chondroitin sulphate, their combina-
tion, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year
results from GAIT. Ann Rheum Dis. 2010;69(8):1459-64, http://dx.doi.
org/10.1136/ard.2009.120469.
39. Gregory PJ, Sperry M, Friedman A. Dietary supplements for osteoar-
thritis. Am Fam Physician. 2008;77(2):177-84.
CLINICS 2014;69(12):847-853 Osteoblast proliferation in rats
Wolff RB
853
